Paul Leeson
Advisory Member
Medicinal Chemistry
HEPTARES
Switzerland
Biography
Paul is a medicinal chemist with more than 35 years’ experience in major pharmaceutical companies. He obtained BSc and PhD degrees in chemistry from the Universities of Liverpool and Cambridge, followed by postdoctoral work at Sussex University. His industrial career began at Smith Kline and French Research Laboratories, and has taken him to Merck Sharp and Dohme, then to Wyeth (USA), and from 1997-2011, AstraZeneca, where he was head of medicinal chemistry at the Charnwood site and leader of AstraZeneca’s Global Chemistry Forum. Since 2011 he has been a consultant for GlaxoSmithKline. Paul’s drug discovery contributions have been in the cardiovascular, neuroscience, respiratory and inflammation therapy areas and he has a special interest in compound quality in relation to pipeline attrition. In 2014 he received the Nauta Award for Pharmacochemistry from the European Federation for Medicinal Chemistry (EFMC).
Research Interest
Medicinal Chemistry
